The overall dental regenerative market is expected to display growth at a few percentage points higher relative to the dental implant market.
Vancouver, BC (PRWEB) December 15, 2014
According to a new report by iData Research, the growth in dental implant placements combined with an increasing prevalence of bone graft usage will drive rapid growth in the number of implants being placed with bone graft substitutes. The total U.S. market for dental bone graft substitutes (BGS) and other dental biomaterials is valued at nearly $341 million in 2014.
“The overall dental regenerative market is expected to display growth at a few percentage points higher relative to the dental implant market,” explains Dr. Kamran Zamanian, CEO of iData. “This correlates with the fact that an increased portion of dental implant procedures are incorporating some sort of bone regenerative product, whether it is a growth factor or a bone graft substitute coupled with a barrier membrane.”
Other key findings from the iData Research report entitled U.S. Dental Bone Grafts Substitutes – 2015:
Increased Number of General Practitioners: An increasing number of general practitioners is expected to perform more bone grafting and implantation procedures, thus further driving the market throughout the forecast period.
Majority Use Resorbable Membranes: Resorbable membranes are especially convenient for smaller bone grafting procedures such as socket preservation, which will increase in usage as the number of GPs who perform dental implant treatment continues to rise.
Technological Developments: The fear of disease transmission has prompted an array of technological innovations in the market for BGS and dental biomaterials. Companies are conducting experiments with different materials and new methods of tissue treatment.
Zimmer Dental has experienced increased revenue recently via sales of its more premium priced CopiOs® Pericardium Membrane and Puros® tissue matrices; both of which are manufactured by RTI Biologics and have boosted Zimmer’s overall market share in the United States.
For Further Information:
This in-depth look at the dental bone grafts market is part of a new report published by iData entitled “U.S. Dental Bone Grafts Substitutes – 2015,” which covers the U.S. dental bone grafts substitutes market as a whole, as well as the following market segments:
- Dental Bone Graft Substitute Markets
- Dental Growth Factor Markets
- Dental Barrier Membrane Markets
- Potential Autograft Markets
- Allograft Markets
- Mineralized Allograft Markets
- DBM Markets
- Xenograft Markets
- Synthetics Markets
- Emdogain™ Markets
- GEM 21S® Markets
- INFUSE® Markets
- Osteocel® Markets
The global series on the “Dental Bone Grafts Substitutes Markets” covers 25 countries including the U.S., Mexico, Brazil, Argentina, China, India, Japan, South Korea, Australia, and 15 countries in Europe.
The full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at info(at)idataresearch(dot)net for a U.S. Dental Bone Grafts Substitutes – 2015 report brochure and synopsis.
iData covers a wide range of other dental global markets. Each of the following categories covers 16 to 25 countries. Visit the iData Research Dental Category page for more details.
- Dental Implants
- Dental CAD / CAM
- Dental Prosthetics
- Dental Imaging
- Dental Lasers
- Dental Materials
- Dental Overtures
- Dental Equipment
- Dental Hygiene
- Dental Instruments
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.